AVID BIOSERVICES, INC.
CDMOUnited States
42 filed reports · 444 financial concepts
Latest figures
Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.
| Figure | Latest fiscal year | Latest quarter |
|---|---|---|
| Revenue | $140MFY2024 · to Apr 30, 2024−6.3% from $149M10-K | $33.5MQ2 FY2025 · to Oct 31, 2024+31.8% from $25.4M10-Q |
| Net income | -$141MFY2024 · to Apr 30, 2024a year earlier: $259K10-K | -$17.4MQ2 FY2025 · to Oct 31, 2024a year earlier: -$9.52M10-Q |
| Operating income | -$18.7MFY2024 · to Apr 30, 2024a year earlier: $3.6M10-K | -$12.6MQ2 FY2025 · to Oct 31, 2024a year earlier: -$11.2M10-Q |
Filed reports
42 reports · Apr 2015 to Oct 2024Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 29 | 3,216 | Jul 2015 to Oct 2024 |
| Annual · 10-KSEC EDGAR | 10 | 3,017 | Apr 2015 to Apr 2024 |
| Quarterly · 10-Q/ASEC EDGAR | 2 | 195 | Jul 2023 to Oct 2023 |
| Annual · 10-K/ASEC EDGAR | 1 | 558 | Apr 2023 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2025 Q2 | 10-Q | Oct 31, 2024 | Dec 10, 2024 | 295 | Open |
| FY2025 Q1 | 10-Q | Jul 31, 2024 | Sep 9, 2024 | 183 | Open |
| FY2024 | 10-K | Apr 30, 2024 | Jul 2, 2024 | 637 | Open |
| FY2024 Q3 | 10-Q | Jan 31, 2024 | Apr 24, 2024 | 150 | Open |
| FY2024 Q2 | 10-Q/A | Oct 31, 2023 | Apr 24, 2024 | 103 | Open |
| FY2024 Q2 | 10-Q | Oct 31, 2023 | Dec 7, 2023 | 1 | Open |
| FY2024 Q1 | 10-Q/A | Jul 31, 2023 | Apr 24, 2024 | 92 | Open |
| FY2024 Q1 | 10-Q | Jul 31, 2023 | Sep 7, 2023 | 1 | Open |
| FY2023 | 10-K/A | Apr 30, 2023 | Apr 24, 2024 | 558 | Open |
| FY2023 | 10-K | Apr 30, 2023 | Jun 21, 2023 | 2 | Open |
| FY2023 Q3 | 10-Q | Jan 31, 2023 | Mar 13, 2023 | 104 | Open |
| FY2022 Q2 | 10-Q | Oct 31, 2022 | Dec 6, 2022 | 98 | Open |
Financial data
444 concepts · 6,986 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial444 concepts · 6,986 facts · Apr 2013 to Oct 2024
- Gross profit (US GAAP)58 · Apr 2013 to Oct 2024
- Net income loss58 · Apr 2013 to Oct 2024
- Revenue58 · Apr 2013 to Oct 2024
- Cash and cash equivalents at carrying value56 · Apr 2013 to Oct 2024
- Net income loss available to common stockholders basic56 · Apr 2013 to Apr 2024
- Capital expenditures incurred but not yet paid54 · Apr 2013 to Oct 2024
- Comprehensive income net of tax54 · Apr 2013 to Oct 2024
- Depreciation depletion and amortization54 · Apr 2013 to Oct 2024
- Increase decrease in accounts payable54 · Apr 2013 to Oct 2024
- Increase decrease in employee related liabilities54 · Apr 2013 to Oct 2024
- Increase decrease in inventories54 · Apr 2013 to Oct 2024
- Increase decrease in other current liabilities54 · Apr 2013 to Oct 2024
- Operating income loss54 · Apr 2013 to Oct 2024
- Payments to acquire property plant and equipment54 · Apr 2013 to Oct 2024
- Selling general and administrative expense54 · Apr 2013 to Oct 2024
- Share based compensation54 · Apr 2013 to Oct 2024
- Stockholders equity (US GAAP)53 · Apr 2013 to Oct 2024
- Accounts payable current51 · Apr 2014 to Oct 2024
- Accounts receivable net current51 · Apr 2014 to Oct 2024
- Accumulated depreciation depletion and amortization property plant and equipment51 · Apr 2014 to Oct 2024
- Additional paid in capital51 · Apr 2014 to Oct 2024
- Assets51 · Apr 2014 to Oct 2024
- Assets current51 · Apr 2014 to Oct 2024
- Common stock par or stated value per share51 · Apr 2014 to Oct 2024
Segments
Figures broken down by business line, region, product or another axis the company reports on.
No segment breakdowns.
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Ask about this company in your AI model
Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.
Use FactIQ to get the revenue, net income and operating income of AVID BIOSERVICES, INC. (CDMO) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 16, 2026) and refreshed every few hours.